Back to Journals » Biologics: Targets and Therapy » Volume 17
Biologics: Targets and Therapy
ISSN: 1177-5491
- View all (502)
- Volume 18, 2024 (6)
- Volume 17, 2023 (17)
- Volume 16, 2022 (18)
- Volume 15, 2021 (40)
- Volume 14, 2020 (13)
- Volume 13, 2019 (17)
- Volume 12, 2018 (19)
- Volume 11, 2017 (14)
- Volume 10, 2016 (18)
- Volume 9, 2015 (17)
- Volume 8, 2014 (27)
- Volume 7, 2013 (28)
- Volume 6, 2012 (46)
- Volume 5, 2011 (9)
- Volume 4, 2010 (31)
- Volume 3, 2009 (45)
- Volume 2, 2008 (89)
- Volume 1, 2007 (48)
Archive: Volume 17, 2023
Hypoxia Inducible Factor-1α Through ROS/NLRP3 Pathway Regulates the Mechanism of Acute Ischemic Stroke Microglia Scorching Mechanism
Ma X, Jiao J, Aierken M, Sun H, Chen L
Biologics: Targets and Therapy 2023, 17:167-180
Published Date: 19 December 2023
The Effect of Two Years of Secukinumab Treatment on Bone Metabolism in Patients with Radiographic Axial Spondyloarthritis: Results from Daily Clinical Practice
Siderius M, Kieskamp SC, Wink F, Kroese FGM, Arends S, Spoorenberg A
Biologics: Targets and Therapy 2023, 17:161-166
Published Date: 14 December 2023
Tocilizumab Vs Methotrexate in a Cohort of Patients Affected by Active GCA: A Comparative Clinical and Ultrasonographic Study
Grazzini S, Conticini E, Falsetti P, D'Alessandro M, Sota J, Terribili R, Baldi C, Fabiani C, Bargagli E, Cantarini L, Frediani B
Biologics: Targets and Therapy 2023, 17:151-160
Published Date: 1 December 2023
Serum LINC00152 and UCA1 in HCV-Induced Hepatocellular Carcinoma: Clinical Significance and Prognostic Value
Shehab-Eldeen S, Essa A, Arafat ES, Sleem AS, Alhosary AA, Darwish E, Essa A, Al-Omair OA, Al-Khoufi EA, Al Abdulqader AK, Nada A
Biologics: Targets and Therapy 2023, 17:137-149
Published Date: 13 October 2023
Treatment Persistence of Apremilast Among Patients with Psoriatic Arthritis
Haddad A, Stein N, Lavi I, Shynkar L, Bergman I, Feldhamer I, Cohen AD, Saliba W, Zisman D
Biologics: Targets and Therapy 2023, 17:129-136
Published Date: 4 October 2023
Molecular Biology Mechanisms and Emerging Therapeutics of Triple-Negative Breast Cancer
Zhang Z, Zhang R, Li D
Biologics: Targets and Therapy 2023, 17:113-128
Published Date: 21 September 2023
Effectiveness of RCTs Pooling Evidence on Mesenchymal Stem Cell (MSC) Therapeutic Applications During COVID-19 Epidemic: A Systematic Review
Kandula UR, Wake AD
Biologics: Targets and Therapy 2023, 17:85-112
Published Date: 18 May 2023
New Uracil Analog with Exocyclic Methylidene Group Can Reverse Resistance to Taxol in MCF-7 Cancer Cells
Długosz-Pokorska A, Perlikowska R, Janecki T, Janecka A
Biologics: Targets and Therapy 2023, 17:69-83
Published Date: 15 May 2023
Treating Alpelisib-Induced Hyperinsulinemia in Patients with Advanced Breast Cancer – A Real-Life Experience
Percik R, Oedegaard Smith C, Leibovici A, Shai A
Biologics: Targets and Therapy 2023, 17:61-67
Published Date: 3 May 2023
Hypereosinophilic Dermatitis: Successful Treatment with Dupilumab
Wu C, Zhang J, Zhao Y
Biologics: Targets and Therapy 2023, 17:57-60
Published Date: 20 April 2023
Demonstration of Safety in Wild Type Mice of npFOXF1, a Novel Nanoparticle-Based Gene Therapy for Alveolar Capillary Dysplasia with Misaligned Pulmonary Veins
Kohram F, Deng Z, Zhang Y, Reza AA, Li E, Kolesnichenko OA, Shukla S, Ustiyan V, Gomez-Arroyo J, Acharya A, Shi D, Kalinichenko VV, Kenny AP
Biologics: Targets and Therapy 2023, 17:43-55
Published Date: 20 March 2023
Critical Response: “Does the Mutation of Cancer Driver Genes IDH1/2 and CD204 Influence Cancer Metabolism and Tumor Associated Macrophage Recruitment in Tumor Microenvironment” [Letter]
Panjaitan NSD, Handayani S, Dewi RM
Biologics: Targets and Therapy 2023, 17:41-42
Published Date: 20 March 2023
Why and How Should Ethiopia Establish a Stem Cell Transplant Service? A Review Article
Mekonnen S, Farris H
Biologics: Targets and Therapy 2023, 17:33-40
Published Date: 20 March 2023
Elevated Serum Vinculin in Patients with HBV/HCV-Associated Liver Cirrhosis and Hepatocellular Carcinoma: A Pilot Study
Essa A, Essa ES, El-deeb SM, Seleem HEM, Al Sahlawi M, Al-Omair OA, Shehab-Eldeen S
Biologics: Targets and Therapy 2023, 17:23-32
Published Date: 19 March 2023
The Cancer Driver Genes IDH1 and IDH2 and CD204 in WHO-Grade 4 Astrocytoma: Crosstalk Between Cancer Metabolism and Tumour Associated Macrophage Recruitment in Tumour Microenvironment
Kurdi M, Mulla N, Katib Y, Alsinani T, Hakamy S, MJ Addas B, Malibary H, Halawa TF, S Farhan M, Faizo E, Baeesa S
Biologics: Targets and Therapy 2023, 17:15-22
Published Date: 5 February 2023
Preliminary Assessment of Safety and Tolerability of Avacopan During the Early Access Program for ANCA-Associated Vasculitis
van Leeuwen JR, Popov T, Obergfell A, Rabelink TJ, Teng YKO
Biologics: Targets and Therapy 2023, 17:11-14
Published Date: 25 January 2023
Significance of Interleukin 23 in Systemic Lupus Patients: Relation to Disease Activity and Damage Indices
Haroon MM, Hegazy GA, Hassanien MA, Shaker O, Hussein WH
Biologics: Targets and Therapy 2023, 17:1-9
Published Date: 18 January 2023